moday - sunday
8.00 am - 9.00 pm
The Covid’19 pandemic has aggravated the decline in mental health worldwide. Numerous studies have highlighted how our life expectancy and overall quality of life is being impacted by an alarming incidence of psychological issues like depression, addiction and self-harm. Research has shown that Psilocybin can provide a safe and effective answer to solving this mental health crisis.
Cyvex International is Ayla’s recently launched subsidiary in Jamaica, setup specifically for the production of Psilocybin. With an initial monthly capacity in excess of 3000 kgs of pharmaceutical grade Psilocybin, Ayla has now become the largest producer of Psilocybin in the world. The Spur-Tree facility spans 38,000 square foot and will eventually reach a capacity of 50 tonnes of Psilocybin per month. This production facility is equipped with state-of-the art equipment and rigid sterility controls that ensure its products are certifiable as pharmaceutical grade ingredients.
What sets Ayla Bioscience apart from other Psilocybin producers is our hybrid strains of Magic Mushrooms that produce as much as ten times more Psilocybin than the wild type strains widely available in the market. Unlike other companies that are dabbling in synthetic processes that are far too expensive to be commercially viable, Ayla’s process allows manufacturing of pharmaceutical grade material at less than 1/100 the cost of synthesized Psilocybin.
Current Psilocybin production for research and treatment is dominated by chemical synthesis, starting with the compound 4-hydroxy indole. This precursor chemical is very expensive, with a $250/gram wholesale cost as of December 2021. The highest average efficiency gained through chemical synthesis is 16%, with each gram of the starting material resulting in 160 mg of pure psilocybin, at a production cost of approximately $1550 per gram - strictly from the cost of the raw materials used. Utilizing Ayla’s technology, Psilocybin can be produced at an efficiency of 75%, using only low-cost glucose as the starting material. Comparing it directly to today’s synthetic chemical method shows a dramatically reduced production cost, making Ayla’s method very attractive as the only feedstock required is glucose, which can be derived from the cell wall material of all plants, cellulose.
In fact, there is no need for any actual primary plant material. Any cellulose-containing secondary plant-derived material can be used as the feedstock. Inputs such as agricultural waste or waste computer paper, or cardboard, sawdust, straw, tobacco scraps, discarded cotton clothing, corn stalks, used pallets; in short, just about anything that was once a living plant can work as a starting material. Starting with this “waste” material, Ayla’s process uses naturally generated fungal enzymes to convert this once-living plant into a high-dollar pharmaceutical raw material worth over $7000 per gram!
Sign in with
google
